We are live on
!
Find out more
FI
Focused Investors Portfolio holdings
AUM
$2.96B
1-Year Est. Return
15.6%
This Fund
S&P 500
This Quarter
Est. Return
-0.98%
1 Year Est. Return
+15.6%
3 Year Est. Return
+51.26%
5 Year Est. Return
+77.43%
10 Year Est. Return
+309.27%
AUM
$3.08B
AUM Growth
-$114M
(-3.6%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-2.02%
Top 10 Holdings %
Top 10 Hldgs %
59.19%
Holding
23
New
–
Increased
3
Reduced
20
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$19.9M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$19.1M |
| 3 |
Walt Disney
DIS
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$25.5M |
| 2 |
Microsoft
MSFT
|
+$24.7M |
| 3 |
Elevance Health
ELV
|
+$7.29M |
| 4 |
Cigna
CI
|
+$5.52M |
| 5 |
Johnson & Johnson
JNJ
|
+$5.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.7% |
| 2 | Technology | 17.33% |
| 3 | Industrials | 17.2% |
| 4 | Financials | 13.66% |
| 5 | Consumer Discretionary | 13.1% |
Similar funds
SSM
VGM
CSIC
BCF
PHAM
SP
B
NC
Focused Investors's Q2 2024 Portfolio in Review
As of Q2 2024, Focused Investors held 23 positions worth $3.08B, down 3.6% from $3.19B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Trading was light in Q2 2024: portfolio turnover was 0%. Focused Investors opened no new positions and made no exits, leaving the 23-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.
- Focused Investors added most to UnitedHealth in Q2 2024, an estimated $19.9M increase.
- Focused Investors's biggest Q2 2024 reduction was Oracle, cutting an estimated $25.5M.
- Focused Investors's ten largest holdings make up 59% of its $3.08B portfolio in Q2 2024.
- Focused Investors opened 0 new positions and closed 0 in Q2 2024.
- Focused Investors's portfolio value fell 3.6% quarter-over-quarter to $3.08B.
Based on Focused Investors's 13F filing for Q2 2024, filed 30 Jul 2024.